Trial intelligence / Profile preview

Bacillus clausii for acute community-acquired diarrhea in Latin American children (cadiLAc)

2016-003444-37Phase 4

Sponsor
Sanofi
Start
Aug 2016
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Phase 4 trial of bacillus clausii in acute diarrhea, sponsored by Sanofi. Primary endpoint: Duration of diarrhea.

02

Drugs

bacillus clausii
03

Conditions

acute diarrhea

Beyond the preview

Go deeper on 2016-003444-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003444-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call